The benefits of this early treatment are still being evaluated, but it is thought that this may prevent development of secondary progressive MS and accumulation of disability.
Lusaphandwa ukhuseleko lolu nyango lwasekuqaleni kwesifo, kodwa lungakuthintela ukuvela kwesifo esikhubaza ngamandla nokukhula kokukhubazeka.